| EMA number | EMEA/H/C/000372 |
| ATC code | B03XA |
| Authorisation | 18 March 2002 |
| Withdrawn | 17 March 2009 |
| Revision | 9 |
Dynepo is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adult patients. It may be used in patients on dialysis and in patients not on dialysis.